Financial services company Ally Financial Inc. (ALLY) announced Friday that Russell Hutchinson will join the company as its chief financial officer, effective July 3, 2023. He will report to Ally CEO Jeffrey Brown and be based in Charlotte, N.C.
Hutchinson brings extensive experience in the financial-services...
PTC Therapeutics Inc. (PTCT) said that its chief executive officer, Stuart Peltz, will retire. Peltz has led the company as its CEO since its founding in 1998 and pioneered the field of RNA-directed drug development.
Matthew Klein, current Chief Operating Officer, has been appointed as its CEO and...
Dawson Geophysical Co. (DWSN) announced Friday that it has entered into an asset purchase agreement with Wilks Brothers, LLC and Breckenridge Geophysical, LLC, pursuant to which the Company purchased substantially all of the Breckenridge assets related to seismic data acquisition services other than...
Western Copper and Gold Corporation (WRN.TO, WRN) announced a strategic equity investment by Mitsubishi Materials Corporation to further advance Western's copper-gold Casino Project in the Yukon. Mitsubishi Materials has agreed to acquire that number of common shares of Western that will represent approximately...
Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and...
GSK PLC (GSK.L, GSK) issued a statement as response to Sargon ruling by the California state court in respect of the Goetz case. The company noted that the scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer.
GSK PLC said the Zantac...
Uniper (UNPRF.PK) announced Carsten Poppinga will become new Chief Commercial Officer on 1 October. Carsten Poppinga is a mathematician and works as Senior Vice President Trading & Origination at Statkraft Markets GmbH in Düsseldorf, a subsidiary of the Norwegian Statkraft AS.
Niek den Hollander,...
Evotec SE (EVO) said Friday that it has received a US$6.6 million grant from The Bill & Melinda Gates Foundation for drug discovery in tuberculosis or "TB".
Evotec noted that the grant is the second award from the foundation to the company supporting TB drug discovery, and allows the company to progress...
TELUS Corp. (TU) said that it has priced $500 million of senior unsecured notes with a 10-year maturity. The notes are offered through a syndicate of agents led by BMO Capital Markets, Scotiabank and TD Securities Inc.
Closing of the offering is expected to occur on or about March 28, 2023.
The...
Celyad Oncology (CYAD) said that it appointed Georges Rawadi as its Chief Executive Officer, with starting date April 17, 2023. Michel Lussier will continue to serve as Interim Chief Executive Officer until April 17 to facilitate transition.
Georges Rawadi has more than 20 years of experience in pharma/biotech,...
Responding to media reports, Air Products (APD) confirmed that it is no longer involved in the coal-to-methanol Bengalon, East Kalimantan, Indonesia project, nor in other coal gasification projects in Indonesia.
The financial landscape for blue and green hydrogen projects has significantly changed...
Costar Technologies Inc. (CSTI.PK) agreed to be acquired by IDIS Co., Ltd. for about $23.2 million.
The deal price includes about $13.0 million to retire Costar's bank debt and with the remainder going to the holders of Costar common stock and vested options after payment of transaction expenses.
After...
Moderna Inc. (MRNA) and Generation Bio Co. (GBIO) have entered into a strategic collaboration to combine Moderna's biological and technical expertise with core technologies of Generation Bio's non-viral genetic medicine platform, Moderna said in a statement on Thursday.
Moderna noted that the collaboration...
United Natural Foods, Inc. (UNFI) announced Thursday that Michael Stigers notified the company of his intention to resign from his position as Chief Executive Officer, UNFI Retail to pursue another professional opportunity.
Stigers will remain with the Company until May 31, 2023 to enable a smooth transition.
Dyne Therapeutics, Inc. (DYN) announced that DYNE-251, an investigational therapeutic for Duchenne muscular dystrophy mutations amenable to exon 51 skipping, was granted FDA orphan drug and rare pediatric disease designations. DYNE-251 is being evaluated in the Phase 1/2 DELIVER clinical trial.
Under...